Clinical Trial

A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty

Name: A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty — clinical trial record (NCT07710430)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

A Single-Arm, Open-Label, Multicenter, Prospective Clinical Study to Evaluate the Effectiveness and Safety of Leuprorelin 1-Month (4-Week) Formulation Administered for 24 Months in Children with Central Precocious Puberty

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-30

Trial Details

NCT Number	NCT07710430
Lead Sponsor	LG Chem
Conditions	Central Precocious Puberty
Enrollment	43 participants
Start Date	2026-08-01
Primary Completion	2029-08-30 (estimated)
Study Completion	2030-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-29